Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.45 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.40 |
| ▸ | PRKAG1 | P54619 | 7/20 | 0.38 |
| ▸ | PRKAA2 | P54646 | 7/20 | 0.38 |
| ▸ | PRKAB1 | Q9Y478 | 7/20 | 0.38 |
| ▸ | PRKAB2 | O43741 | 5/20 | 0.37 |
| ▸ | PRKAA1 | Q13131 | 5/20 | 0.37 |
| ▸ | PRKAG3 | Q9UGI9 | 5/20 | 0.37 |
| ▸ | PRKAG2 | Q9UGJ0 | 5/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.35 |
| ▸ | F7 | P08709 | 1/20 | 0.34 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.34 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.34 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.34 |
| ▸ | EIF4A3 | P38919 | 1/20 | 0.33 |
| ▸ | GRK6 | P43250 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4155339 | 0.87 | CAMKK2 (0.40) | FASNGPR17S1PR1PTGER3F7 | |
| SCHEMBL3249044 | 0.85 | PRKAG1 (0.48) | FASNPRKAG1PRKAA2PRKAB1PRKAB2 | |
| SCHEMBL4153846 | 0.81 | CAMKK2 (0.39) | FASNS1PR1F7CAMKK2GRK6 | |
| SCHEMBL3252420 | 0.80 | FASN (0.44) | FASNPRKAG1PRKAA2PRKAB1PRKAB2 | |
| Propionic Acid SCHEMBL4159324 | 0.79 | FASN (0.48) | FASNPRKAG1PRKAA2PRKAB1PRKAB2 | |
| SCHEMBL3241835 | 0.79 | FASN (0.43) | FASNPRKAG1PRKAA2PRKAB1PRKAB2 | |
| SCHEMBL4157978 | 0.78 | HPGD (0.39) | GPR17S1PR1F7 | |
| SCHEMBL4155187 | 0.78 | HPGD (0.38) | GPR17 | |
| SCHEMBL13950957 | 0.77 | FASN (0.44) | FASNPRKAG1PRKAA2PRKAB1PRKAB2 | |
| SCHEMBL4155350 | 0.76 | GPR17 (0.46) | GPR17PRKAG1PRKAA2PRKAB1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426437-B2 | Pyrroloquinoline derivatives and their use as protein kinases inhibitors | PIERRE FABRE MEDICAMENT (FR) | 2013-04-23 | — | — | US | claimed |
| US-20090042876-A1 | Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors | PIERRE FABRE MEDICAMENT (FR) | 2009-02-12 | — | — | US | claimed |
| US-8426437-B2 | Pyrroloquinoline derivatives and their use as protein kinases inhibitors | PIERRE FABRE MEDICAMENT (FR) | 2013-04-23 | — | — | US | disclosed |
| US-20090042876-A1 | Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors | PIERRE FABRE MEDICAMENT (FR) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042876-A1 | Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors | MAP3K1, MAP3K2, MAP3K7 | FASN 2527/4885GPR17 2461/4885PRKAG1 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.